Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Thrombosis and Haemostasis|October 18, 1993
Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172)H N MagnaniThrombosis Research|November 21, 2009
A review of 122 published outcomes of danaparoid anticoagulation for intermittent haemodialysisH N MagnaniThrombosis Research|August 7, 2009
An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran)H N MagnaniBiochimica Et Biophysica Acta|December 20, 1976
The influence of LP-X and other lipoproteins associated with hepatic dysfunction on the activity of lecithin:cholesterol acyltransferaseH N MagnaniGastroenterology|July 1, 1976
Utilization of the quantitative assay of lipoprotein X in the differential diagnosis of extraphepatic obstructive jaundice and intrahepatic diseasesH N Magnani, P AlaupovicJournal of Clinical Pathology|December 1, 1971
A quantitative method for blood lipoproteins using cellulose acetate electrophoresisH N Magnani, A N HowardHamostaseologie|May 5, 2007
[Danaparoid in pregnancy in cases of heparin intolerance - use in 59 cases]M Schindewolf, H N Magnani, E Lindhoff-LastEuropean Journal of Pediatrics|January 29, 2000
Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodiumO Ranze, P Ranze, H N Magnani, et al.Thrombosis Research|March 1, 1987
Early clinical experience of a new heparinoid, Org 10172, in prevention of deep venous thrombosisJ F Cade, M Wood, H N Magnani, et al.Pageof 2